Johnson & Johnson (NYSE:JNJ)
$ 263.4 -3.84 (-1.44%) Market Cap: 634.06 Bil Enterprise Value: 667.00 Bil PE Ratio: 30.45 PB Ratio: 7.81 GF Score: 81/100

Johnson & Johnson at Barclays Global Healthcare Conference Transcript

Mar 10, 2026 / 03:30PM GMT
Release Date Price: $243.71 (+0.46%)
Matt Miksic
Barclays Services Corp - Analyst

All right. It's still morning, so good morning, everybody. Very happy to have with us this year from J&J, Hani Abouhalka, Group Chairman of Surgery, otherwise known as the man behind the robot. And my name is Matt Miksic. I cover MedTech here at Barclays, so exciting times at Johnson & Johnson and Surgery.

Questions & Answers

Matt Miksic;Hani Abouhalka
Barclays Services Corp - Analyst;

After a bunch of years, we won't go backwards, we'll go forwards, but a long path with lots of twists and turns, but now kind of a final stretch of potentially getting this robot to market. So maybe with that kind of perspective, we get a lot of questions sometimes on why does J&J want to have a robot, why do they need to have a robot, what can the robot add?

I know that not everything you put together was in response to the marketplace, but at a high level, maybe frame the objectives of the project and the strategy behind the project as you're currently executing it.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot